Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
16.69
+0.42 (2.58%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Evolus Revenue
Evolus had revenue of $66.91M in the quarter ending June 30, 2024, with 35.59% growth. This brings the company's revenue in the last twelve months to $237.26M, up 40.71% year-over-year. In the year 2023, Evolus had annual revenue of $202.09M with 35.98% growth.
Revenue (ttm)
$237.26M
Revenue Growth
+40.71%
P/S Ratio
4.15
Revenue / Employee
$869,084
Employees
273
Market Cap
1.05B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Owens & Minor | 10.53B |
OPKO Health | 716.37M |
Maravai LifeSciences Holdings | 278.59M |
Aurinia Pharmaceuticals | 207.11M |
BioLife Solutions | 139.96M |
Arcutis Biotherapeutics | 132.06M |
IGM Biosciences | 2.91M |
Applied Therapeutics | -333.00K |
EOLS News
- 18 hours ago - Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers - Business Wire
- 6 days ago - Evolus to Report Third Quarter Financial Results on November 6, 2024 - Business Wire
- 18 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024 - Business Wire
- 3 months ago - Evolus, Inc. (EOLS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Evolus reports first-ever adjusted profit in Q2 fueled by strong sales of Botox rival - Reuters
- 3 months ago - Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance - Business Wire
- 3 months ago - Evolus to Hold Investor Day on September 12, 2024 - Business Wire